Aspira Women’s Health entered into a Subordinated Business Loan and Security Agreement to obtain a $1.05 million secured term loan. The note carries expected interest charges of $441,000 if paid on schedule and matures on Jan 26, 2027. The loan is subordinated to senior debt and secured by substantially all personal property, with financing statements permitted upon an event of default. Proceeds will refinance a January loan and support general corporate purposes.
Agreement details:
- Agreement type: Subordinated secured term loan and security agreement
- Counterparty: Agile Lending (lead lender) and Agile Capital Funding (collateral agent)
- Signed / Effective: Jul 06 2026 / Jul 01 2026
- Duration / Termination: Through Jan 26 2027
- Reason: Refinance January loan and fund general corporate purposes
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.